Epilepsy and hearing loss as risk factors for later Parkinson?

A new paper “Identifying Parkinson Risk Markers in Primary Care—Old Associations and New Insights” was published in
JAMA Neurology written by, Bhavana Patel, DO; Shannon Chiu, MD;  and Melissa J. Armstrong, MD, MSc  with an editorial by Bhavana Patel

was published in the March 7, 2022 issue.

Timely identification of individuals at risk for neurodegenerative diseases such as Parkinson disease (PD) is increasingly important as more neuroprotective agents are investigated. Improving early diagnosis may facilitate access to clinical trials now and prepare for the future availability of disease-modifying treatments. Early diagnoses may also facilitate pharmacologic and nonpharmacologic therapies with the potential to improve quality of life. In addition, an early diagnosis is important for families and caregivers to understand the symptoms their loved ones may be experiencing and prepare for the future.